(Q34809194)

4 August 2017

1 reference

title

Lipid peroxidation in aging brain and Alzheimer's disease (English)

1 reference

4 August 2017

0 references

Joseph F Quinn

3

0 references

M. Flint Beal

4

object named as

M Flint Beal

1 reference

4 August 2017

1

Thomas J Montine

1 reference

4 August 2017

William R. Markesbery

5

object named as

William R Markesbery

1 reference

4 August 2017

M Diana Neely

2

1 reference

4 August 2017

L Jackson Roberts

6

1 reference

4 August 2017

Jason D Morrow

7

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Free Radical Biology and Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

33

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

620-626

1 reference

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Mechanisms of free radical oxidation of unsaturated lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Acrolein inhibits respiration in isolated brain mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Expression and activities of aldo-keto oxidoreductases in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Biologically active oxidized phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Increased CSF F2-isoprostane concentration in probable AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

The isoprostanes: unique bioactive products of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Amyloid-β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Measurement of lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

The measurement and mechanism of lipid peroxidation in biological systems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

The free radical theory of aging matures

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2802%2900807-9

7 January 2021

10.1016/S0891-5849(02)00807-9

Identifiers

DOI

1 reference

4 August 2017

1 reference